106 related articles for article (PubMed ID: 7478583)
1. Identification of an antisense WT1 promoter in intron 1: implications for WT1 gene regulation.
Malik KT; Wallace JI; Ivins SM; Brown KW
Oncogene; 1995 Oct; 11(8):1589-95. PubMed ID: 7478583
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the Wilms' tumour suppressor (WT1) gene by an antisense RNA: a link with genomic imprinting?
Ward A; Dutton JR
J Pathol; 1998 Aug; 185(4):342-4. PubMed ID: 9828831
[TBL] [Abstract][Full Text] [Related]
3. Cloning of novel Wilms tumor gene (WT1) cDNAs; evidence for antisense transcription of WT1.
Eccles MR; Grubb G; Ogawa O; Szeto J; Reeve AE
Oncogene; 1994 Jul; 9(7):2059-63. PubMed ID: 8208551
[TBL] [Abstract][Full Text] [Related]
4. Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro.
Moorwood K; Charles AK; Salpekar A; Wallace JI; Brown KW; Malik K
J Pathol; 1998 Aug; 185(4):352-9. PubMed ID: 9828833
[TBL] [Abstract][Full Text] [Related]
5. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J
Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
8. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
9. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
McCoy C; McGee SB; Cornwell MM
Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
[TBL] [Abstract][Full Text] [Related]
10. Antisense transcripts and protein binding motifs within the Wilms tumour (WT1) locus.
Campbell CE; Huang A; Gurney AL; Kessler PM; Hewitt JA; Williams BR
Oncogene; 1994 Feb; 9(2):583-95. PubMed ID: 8290269
[TBL] [Abstract][Full Text] [Related]
11. Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1.
Li RS; Law GL; Seifert RA; Romaniuk PJ; Morris DR
Exp Cell Res; 1999 Feb; 247(1):257-66. PubMed ID: 10047468
[TBL] [Abstract][Full Text] [Related]
12. Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.
Warnecke C; Willich T; Holzmeister J; Bottari SP; Fleck E; Regitz-Zagrosek V
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):17-24. PubMed ID: 10229654
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2.
McConnell MJ; Cunliffe HE; Chua LJ; Ward TA; Eccles MR
Oncogene; 1997 Jun; 14(22):2689-700. PubMed ID: 9178767
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the transcriptional regulatory region of the human WT1 gene.
Hofmann W; Royer HD; Drechsler M; Schneider S; Royer-Pokora B
Oncogene; 1993 Nov; 8(11):3123-32. PubMed ID: 8414514
[TBL] [Abstract][Full Text] [Related]
16. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ
Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739
[TBL] [Abstract][Full Text] [Related]
17. Activation of the WT1 tumor suppressor gene promoter by Pea3.
Discenza MT; Vaz D; Hassell JA; Pelletier J
FEBS Lett; 2004 Feb; 560(1-3):183-91. PubMed ID: 14988020
[TBL] [Abstract][Full Text] [Related]
18. CART gene promoter transcription is regulated by a cyclic adenosine monophosphate response element.
Barrett P; Davidson J; Morgan P
Obes Res; 2002 Dec; 10(12):1291-8. PubMed ID: 12490674
[TBL] [Abstract][Full Text] [Related]
19. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells.
Nichols KE; Re GG; Yan YX; Garvin AJ; Haber DA
Cancer Res; 1995 Oct; 55(20):4540-3. PubMed ID: 7553624
[TBL] [Abstract][Full Text] [Related]
20. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
